Skip to content
Events
Media
Subscribe
Donate
What We Do
Focus Areas
Sexual and Reproductive Health, Rights, and Choices
Adolescents and Young People
Gender Equality and Equity
Climate and Environmental Changes
Research
Featured Projects
Biomedical Development
Population and Development Review Journal
Studies in Family Planning Journal
Publications Library
Where We Work
Countries
Overview
Bangladesh
Egypt
Ethiopia
Ghana
Guatemala
India
Kenya
Mexico
Nigeria
Pakistan
Senegal
South Africa
United States
Zambia
Innovation Hubs
Center for Biomedical Research (CBR)
Girl Innovation, Research, and Learning (GIRL) Center
Humanitarian Task Force (HTF)
Population, Environmental Risks, and the Climate Crisis (PERCC) Initiative
Gender, Education, Justice, and Equity (GEJE)
Insights
About Us
Strategic Plan
Diversity, Equity, and Inclusion
Ethical Standards
Leadership
Board of Trustees
People
Fellowships
Careers
Financials
Partner with Us
Contact Us
Search for:
Menu
Close
Search for:
Toggle Navigation
What We Do
Focus Areas
Sexual and Reproductive Health, Rights, and Choices
Adolescents and Young People
Gender Equality and Equity
Climate and Environmental Changes
Research
Featured Projects
Biomedical Development
Population and Development Review Journal
Studies in Family Planning Journal
Publications Library
Where We Work
Countries
Overview
Bangladesh
Egypt
Ethiopia
Ghana
Guatemala
India
Kenya
Mexico
Nigeria
Pakistan
Senegal
South Africa
United States
Zambia
Innovation Hubs
Center for Biomedical Research (CBR)
Girl Innovation, Research, and Learning (GIRL) Center
Humanitarian Task Force (HTF)
Population, Environmental Risks, and the Climate Crisis (PERCC) Initiative
Gender, Education, Justice, and Equity (GEJE)
Insights
About Us
Strategic Plan
Diversity, Equity, and Inclusion
Ethical Standards
Leadership
Board of Trustees
People
Fellowships
Careers
Financials
Partner with Us
Contact Us
Toggle Navigation
Events
Media
Subscribe
Donate
Press Release
First Trial Launches to Test Effectiveness of Male Contraceptive Gel
NES/T is a novel, reversible contraceptive for men designed to be absorbed through the skin.
FDA Approves the First One-Year Contraceptive Fully under a Woman’s Control
FDA approval marks an important step toward expanding contraceptive options for women.
Population Council Announces New License Agreement
New agreement will make the Council's one-year vaginal system for contraception available to women in the US.
First Multipurpose Gel Designed to Prevent HIV, HSV, and HPV Simultaneously in Women and Men Advances in Clinical Trials
If proven effective, PC-1005 gel would be the first product to prevent three incurable STIs—HIV, HSV, and HPV.
Population Council Advances Non-Antiretroviral Multipurpose Prevention Technology For HIV and STI Prevention to Clinical Trial
First in-human clinical trial of griffithsin, a naturally occurring anti-HIV protein, which limits risk of cross-resistance to antiretroviral (ARV) products.
Population Council Awarded Breakthrough-RESEARCH Project by USAID
The project aims to improve healthy behaviors and norms across key global health areas.
New GIRL Center to Shape Research and Investments on What Works to Improve Girls’ Lives
The Council launches the Girl Innovation, Research, and Learning (GIRL) Center.
‹
1
…
3
4
5
Page load link
Go to Top